In 2013 Science magazine declared Cancer Immunotherapy the breakthrough of the year. This heralded the era of a different form of cancer treatment. In contrast to therapies such as radiation and cytotoxic drugs (chemotherapy) that directly kill the patient’s tumor, immunotherapies act on the patient’s immune system, training and augmenting its ability to kill tumor cells.
Canine Cancer Patients Help Lead the Way
PRECINCT
“Our mission is to provide infrastructure and oversight to a highly collaborative and interactive network of researchers and clinician scientists working to accelerate the application of next generation immunotherapies through comparative oncology.”
Event
Event
About
Projects
Partner on our mission!
Comparative oncology is…
To evaluate therapies that act on a patient’s immune system…
To evaluate therapies that act on a patient’s immune system…
Why Study Cancer Immunotherapy?
Canine Cancers
- Lymphoma
- Osteosarcoma
- Malignant Melanoma
- Glioblastoma
Get the Latest
